Cardiomyopathies remain a serious yet underrecognized area within cardiology in the Netherlands. Despite growing knowledge of their genetic and pathophysiological […]
Listen to the podcasts: A patient’s testimony by Sophie Charlier (in French): Cardiomyopathies explained by Prof. Van Craenenbroeck (in Dutch):
New Infographic: Why EU Cardiovascular Policies Must Tackle Cardiomyopathies We are excited to introduce CMatter’s latest infographic, EU Cardiovascular Disease
Cardiomyopathies, a group of diseases affecting the heart muscle, are often neglected despite the significant burden they pose on individuals
Cardiomyopathies Matter Spain will present a report identifying key challenges and unmet needs throughout the Spanish patient care pathway and
Cardiomyopathies, a group of diseases affecting the heart muscle, are often neglected despite the significant burden they pose on individuals
In cardiomyopathy care, family matters. A causative genetic variant can be identified in around 20–60% of cases of the main
The Cardiomyopathies Matter Roadmap is the first comprehensive report providing policy solutions to the unmet needs and challenges of cardiomyopathies.
The Cardiomyopathies Matter initiative celebrated its official launch on the 15th of November 2022 in the European Parliament. This high-level
